tradingkey.logo
搜索
市场行情
自选
新闻
分析
交易工具
选股器
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
搜索

Travere Therapeutics Inc

TVTX
添加自选
62.760USD
-1.980-3.06%
收盘 09-18 16:00（美东）
5.91B总市值
亏损市盈率 TTM
盘后交易 16:01 (美东)62.960USD+0.180+0.29%

Travere Therapeutics Inc

62.760
-1.980-3.06%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要利润表资产负债表现金流量表公司收入财报公司估值风险评估

概览

新闻分析

财务

股票评分

技术分析

预测

持股情况

股息

公司资料

财务摘要利润表资产负债表现金流量表公司收入财报公司估值风险评估

TVTX 财务数据

通过专为投资者打造的一站式数据看板，全面查看 Travere Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图，助您更轻松地进行财务分析。您可以查看最新年度财务报告，也可以通过利润表、资产负债表和现金流量表，按季度分析公司表现。借助实时财务指标，持续追踪公司的经营状况和市场表现更加便捷。

关键财务比率

总市值
5.91B
股息TTM
0.00
市盈率 TTM
-280.77
每股收益TTM
-0.22
营业收入
490.73M
净利润
-321.55M
净资产收益率
-69.38%
总资产收益率
-8.27%

Travere Therapeutics Inc 财报日历

最新发布
8月 4, 2026
每股收益 / 预测值
-0.37/-0.14
营业收入 / 预测值
169.58M/159.59M

财务报表摘要

单季报
单季报+年报
单季报
年报
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
-159.58%-0.37
13.44%-0.40
104.17%0.03
140.88%0.29
84.22%-0.14
73.55%-0.47
38.50%-0.72
-135.67%-0.70
19.60%-0.91
-39.29%-1.76
-15.00%-1.18
--1.98
---1.13
---1.27
---1.02
---3.34
----
----
----
----
营业收入
48.17%169.58M
55.63%127.20M
73.41%129.69M
162.11%164.86M
111.49%114.45M
97.54%81.73M
65.98%74.79M
69.56%62.90M
68.08%54.12M
33.95%41.37M
53.58%45.06M
32.13%37.09M
-40.56%32.20M
-36.30%30.89M
-48.75%29.34M
-58.84%28.07M
-0.82%54.17M
2.28%48.49M
12.29%57.25M
33.40%68.22M
净利润
-172.81%-34.80M
10.00%-37.10M
104.53%2.73M
146.90%25.71M
81.88%-12.76M
69.70%-41.23M
33.17%-60.26M
-136.36%-54.81M
17.78%-70.41M
-57.60%-136.06M
-36.99%-90.17M
316.40%150.74M
-27.74%-85.63M
-13.64%-86.33M
-27.63%-65.82M
-95.45%-69.66M
-71.82%-67.03M
-41.03%-75.97M
57.60%-51.57M
-58.05%-35.64M
利润率
-84.11%-20.52%
42.95%-28.78%
78.96%-16.95%
117.91%15.59%
91.34%-11.14%
84.65%-50.44%
59.01%-80.59%
63.82%-87.05%
59.35%-128.71%
-5.11%-328.61%
32.64%-196.62%
---240.57%
---316.60%
---312.63%
---291.88%
---306.83%
----
----
----
----
毛利率
-2.25%96.45%
4.45%98.47%
1.50%98.03%
1.67%99.04%
2.58%98.67%
-2.17%94.28%
7.47%96.59%
0.92%97.41%
0.73%96.19%
11.30%96.36%
-7.39%89.87%
--96.53%
--95.49%
--86.58%
--97.04%
--95.57%
----
----
----
----
资产负债率
10.24%75.41%
-18.70%56.21%
-19.25%51.51%
-22.97%57.81%
-0.30%68.40%
21.46%69.14%
33.39%63.79%
65.87%75.05%
34.24%68.61%
22.36%56.92%
-14.36%47.82%
--45.25%
--51.11%
--46.52%
--55.84%
--51.65%
----
----
----
----
利润表
营业收入
48.17%169.58M
55.63%127.20M
73.41%129.69M
162.11%164.86M
111.49%114.45M
97.54%81.73M
65.98%74.79M
69.56%62.90M
68.08%54.12M
33.95%41.37M
53.58%45.06M
32.13%37.09M
-40.56%32.20M
-36.30%30.89M
-48.75%29.34M
-58.84%28.07M
-0.82%54.17M
2.28%48.49M
12.29%57.25M
33.40%68.22M
营业利润
131.26%3.95M
13.50%-36.91M
45.35%-32.43M
144.50%24.93M
81.13%-12.65M
42.15%-42.67M
28.37%-59.33M
39.49%-56.03M
35.50%-67.05M
24.23%-73.77M
4.46%-82.84M
-12.08%-92.58M
-71.69%-103.95M
-70.67%-97.37M
-77.34%-86.70M
-362.85%-82.60M
-79.09%-60.54M
-46.42%-57.05M
-93.91%-48.89M
-24.37%-17.85M
净利润
-172.81%-34.80M
10.00%-37.10M
104.53%2.73M
146.90%25.71M
81.88%-12.76M
69.70%-41.23M
33.17%-60.26M
-136.36%-54.81M
17.78%-70.41M
-57.60%-136.06M
-36.99%-90.17M
316.40%150.74M
-27.74%-85.63M
-13.64%-86.33M
-27.63%-65.82M
-95.45%-69.66M
-71.82%-67.03M
-41.03%-75.97M
57.60%-51.57M
-58.05%-35.64M
资产负债表
流动资产
62.06%615.14M
4.95%392.68M
5.01%437.56M
14.28%371.11M
2.87%379.57M
-22.22%374.17M
-32.44%416.70M
-52.68%324.74M
-31.93%368.98M
-20.47%481.08M
26.79%616.77M
28.31%686.23M
-7.62%542.05M
-4.15%604.90M
-16.54%486.44M
-7.64%534.84M
6.73%586.78M
11.69%631.09M
42.01%582.83M
16.36%579.08M
流动负债总额
-19.79%152.03M
-31.25%125.44M
-20.35%159.90M
-28.92%135.07M
56.30%189.54M
5.33%182.46M
12.84%200.75M
36.29%190.04M
-10.64%121.27M
32.60%173.23M
25.14%177.91M
6.41%139.43M
9.01%135.71M
9.35%130.65M
14.57%142.16M
15.79%131.03M
28.37%124.49M
40.53%119.47M
33.92%124.09M
50.03%113.16M
总资产
43.95%799.36M
1.16%555.19M
1.86%605.19M
6.77%538.58M
0.76%555.31M
-17.29%548.80M
-24.69%594.13M
-39.44%504.41M
-25.16%551.12M
-17.90%663.55M
17.30%788.91M
14.68%832.85M
-5.52%736.43M
-2.44%808.23M
-13.40%672.59M
-6.30%726.22M
4.38%779.49M
8.42%828.40M
27.85%776.63M
11.97%775.08M
总负债
48.28%774.84M
-11.53%456.46M
-8.35%490.36M
-13.06%465.02M
-2.50%522.56M
-12.47%515.98M
-9.02%535.05M
-3.29%534.86M
-13.54%535.97M
-4.78%589.48M
-6.61%588.10M
-11.58%553.08M
-0.46%619.94M
-0.19%619.09M
32.71%629.73M
33.75%625.54M
50.26%622.78M
54.54%620.26M
19.76%474.52M
19.68%467.70M
总权益
-25.12%24.52M
200.79%98.73M
94.37%114.83M
341.56%73.56M
116.19%32.75M
-55.69%32.82M
-70.58%59.08M
-110.89%-30.45M
-87.00%15.15M
-60.84%74.07M
368.62%200.81M
177.89%279.77M
-25.67%116.48M
-9.13%189.14M
-85.82%42.85M
-67.25%100.68M
-52.84%156.71M
-42.61%208.14M
43.04%302.11M
1.98%307.37M
现金流量表
经营净额
1065.38%58.07M
4.33%-40.37M
311.93%60.68M
133.64%14.32M
112.48%4.98M
64.51%-42.19M
55.52%-28.63M
61.51%-42.56M
42.37%-39.93M
-46.58%-118.90M
-17.81%-64.37M
-179.75%-110.57M
-88.28%-69.30M
-46.63%-81.12M
-103.30%-54.64M
-223.27%-39.52M
-666.59%-36.81M
-108.96%-55.32M
-93.78%-26.88M
376.07%32.06M
投资净额
-4353.34%-206.29M
-47.81%21.55M
-30.54%-104.84M
87.73%86.59M
-83.05%4.85M
-60.64%41.29M
-341.79%-80.31M
163.31%46.13M
221.47%28.61M
383.21%104.90M
50.47%-18.18M
-822.85%-72.86M
39.76%-23.55M
-211.68%-37.04M
-597.98%-36.70M
-69.01%10.08M
45.55%-39.10M
131.37%33.16M
105.87%7.37M
175.33%32.52M
融资净额
12613.02%187.52M
13.07%4.20M
-80.82%26.68M
-142141.30%-65.34M
88.62%1.48M
808.19%3.72M
36223.50%139.12M
112.30%46.00K
-69.03%782.00K
-100.24%-525.00K
-30.49%383.00K
-116.42%-374.00K
203.85%2.52M
91.02%217.60M
-98.52%551.00K
-26.04%2.28M
-14.33%831.00K
-42.02%113.91M
44.38%37.25M
604.81%3.08M

营业收入

业务

报告期:
暂无数据

地区

报告期:
暂无数据

常见问题

Travere Therapeutics Inc的总收入是多少？

根据Travere Therapeutics Inc的FY2025财报，总收入达到了490.73M（同比变化233.18M）。

Travere Therapeutics Inc的流动资产是多少？

根据Travere Therapeutics Inc的FY2025财报，流动资产为437.56M（同比变化5.01）。

Travere Therapeutics Inc的总资产是多少？

根据Travere Therapeutics Inc的FY2025财报，Travere Therapeutics Inc的总资产为605.19M（同比变化1.86）。

Travere Therapeutics Inc的总负债是多少？

根据Travere Therapeutics Inc的FY2025财报，Travere Therapeutics Inc的总负债为490.36M（同比变化-8.35）。

Travere Therapeutics Inc的总权益是多少？

根据Travere Therapeutics Inc的FY2025财报，Travere Therapeutics Inc的总权益为114.83M（同比变化94.37）。

Travere Therapeutics Inc的净营业收入是多少？

根据Travere Therapeutics Inc的FY2025财报，Travere Therapeutics Inc的净营业收入为-62.82M（同比变化75.48）。

Travere Therapeutics Inc的净投资是多少？

根据Travere Therapeutics Inc的FY2025财报，Travere Therapeutics Inc的净投资为27.89M（同比变化-71.92）。

Travere Therapeutics Inc的净融资是多少？

根据Travere Therapeutics Inc的FY2025财报，Travere Therapeutics Inc的净融资为-33.47M（同比变化-124.00）。

Travere Therapeutics Inc的每股收益（EPS）是多少？

根据Travere Therapeutics Inc的FY2025财报，每股收益（EPS）为-0.29（同比变化92.97）。

Travere Therapeutics Inc的净利润是多少？

根据Travere Therapeutics Inc的FY2025财报，净利润为-25.55M（同比变化92.06）。

Travere Therapeutics Inc的净利润率是多少？

根据Travere Therapeutics Inc的FY2025财报，净利润率为-10.24（同比变化92.55）。

Travere Therapeutics Inc的毛利率是多少？

根据Travere Therapeutics Inc的FY2025财报，毛利率为97.89（同比变化1.26）。

Travere Therapeutics Inc的债务与资产比率是多少？

根据Travere Therapeutics Inc的FY2025财报，债务与资产比率为51.51（同比变化-19.25）。

Travere Therapeutics Inc的股东权益回报率（ROE）是多少？

根据Travere Therapeutics Inc的FY2025财报，股东权益回报率（ROE）为-57.80（同比变化76.57）。

Travere Therapeutics Inc的资产回报率（ROA）是多少？

根据Travere Therapeutics Inc的FY2025财报，资产回报率（ROA）为-8.38（同比变化81.92）。

Travere Therapeutics Inc的营业利润是多少？

根据Travere Therapeutics Inc的FY2025财报，营业利润为-62.82M（同比变化75.48）。
tradingkey.logo
风险提示：我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐，且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险，包括可能损失投资的本金，且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告，并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有
一般使用条款
隐私政策
Cookie政策